129 related articles for article (PubMed ID: 8080451)
21. Effects of a bolus injection of 5-fluorouracil on dihydropyrimidine dehydrogenase activity in rats receiving continuous infusion of 5-fluorouracil.
Kobuchi S; Hayashi A; Taniguchi M; Ito Y; Tamura T; Sakaeda T
Cancer Chemother Pharmacol; 2016 Sep; 78(3):517-23. PubMed ID: 27417318
[TBL] [Abstract][Full Text] [Related]
22. [Dihydropyrimidine dehydrogenase activity in lymphocytes: predictive factor for 5-fluorouracil clearance].
Etienne MC; Milano G; Fleming RA; Thyss A; Renée N; Schneider M; Demard F
Bull Cancer; 1992; 79(12):1159-63. PubMed ID: 1304835
[TBL] [Abstract][Full Text] [Related]
23. Indirect assessment of dihydropyrimidine dehydrogenase activity in cats.
Saba CF; Schmiedt CW; Freeman KG; Edwards GL
Vet Comp Oncol; 2013 Dec; 11(4):265-71. PubMed ID: 24007333
[TBL] [Abstract][Full Text] [Related]
24. Population characteristics of hepatic dihydropyrimidine dehydrogenase activity, a key metabolic enzyme in 5-fluorouracil chemotherapy.
Lu Z; Zhang R; Diasio RB
Clin Pharmacol Ther; 1995 Nov; 58(5):512-22. PubMed ID: 7586945
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous determination of dihydrofluorouracil and 5-fluorouracil in plasma by high-performance liquid chromatography.
Ackland SP; Garg MB; Dunstan RH
Anal Biochem; 1997 Mar; 246(1):79-85. PubMed ID: 9056186
[TBL] [Abstract][Full Text] [Related]
26. Dihydropyrimidine dehydrogenase in livers from mouse and rat, and in human liver, colon tumors, and mucosa in relation to anabolism of 5-fluorouracil.
Peters GJ; van Groeningen CJ; Pinedo HM
Adv Exp Med Biol; 1998; 431():633-6. PubMed ID: 9598142
[No Abstract] [Full Text] [Related]
27. Purification and characterization of dihydropyrimidine dehydrogenase from Alcaligenes eutrophus.
Schmitt U; Jahnke K; Rosenbaum K; Cook PF; Schnackerz KD
Arch Biochem Biophys; 1996 Aug; 332(1):175-82. PubMed ID: 8806723
[TBL] [Abstract][Full Text] [Related]
28. Sex- or age-related differences were not detected in the activity of dihydropyrimidine dehydrogenase from rat liver.
Tateishi T; Watanabe M; Nakura H; Tanaka M; Kumai T; Kobayashi S
Pharmacol Res; 1997 Feb; 35(2):103-6. PubMed ID: 9175577
[TBL] [Abstract][Full Text] [Related]
29. Acid base catalytic mechanism of the dihydropyrimidine dehydrogenase from pH studies.
Podschun B; Jahnke K; Schnackerz KD; Cook PF
J Biol Chem; 1993 Feb; 268(5):3407-13. PubMed ID: 8429016
[TBL] [Abstract][Full Text] [Related]
30. Phenotyping of Uracil and 5-Fluorouracil Metabolism Using LC-MS/MS for Prevention of Toxicity and Dose Adjustment of Fluoropyrimidines.
Tafzi N; Woillard JB; Fleytoux A; Picard N; Marquet P
Ther Drug Monit; 2020 Aug; 42(4):540-547. PubMed ID: 32384537
[TBL] [Abstract][Full Text] [Related]
31. Association between the pharmacokinetics of capecitabine and the plasma dihydrouracil to uracil ratio in rat: A surrogate biomarker for dihydropyrimidine dehydrogenase activity.
Kobuchi S; Akutagawa M; Ito Y; Sakaeda T
Biopharm Drug Dispos; 2019 Jan; 40(1):44-48. PubMed ID: 30592773
[TBL] [Abstract][Full Text] [Related]
32. 5-fluorouracil sensitivity and dihydropyrimidine dehydrogenase activity in advanced gastric cancer.
Inada T; Ogata Y; Kubota T; Tomikawa M; Yamamoto S; Andoh J; Ozawa I; Hishinuma S; Shimizu H; Kotake K
Anticancer Res; 2000; 20(4):2457-62. PubMed ID: 10953310
[TBL] [Abstract][Full Text] [Related]
33. Pyrimidine catabolism in Pseudomonas aeruginosa.
Kim S; West TP
FEMS Microbiol Lett; 1991 Jan; 61(2-3):175-9. PubMed ID: 1903745
[TBL] [Abstract][Full Text] [Related]
34. Purification and characterization of dihydropyrimidine dehydrogenase from human liver.
Lu ZH; Zhang R; Diasio RB
J Biol Chem; 1992 Aug; 267(24):17102-9. PubMed ID: 1512248
[TBL] [Abstract][Full Text] [Related]
35. Predicting 5-fluorouracil toxicity: DPD genotype and 5,6-dihydrouracil:uracil ratio.
Sistonen J; Büchel B; Froehlich TK; Kummer D; Fontana S; Joerger M; van Kuilenburg AB; Largiadèr CR
Pharmacogenomics; 2014 Sep; 15(13):1653-66. PubMed ID: 25410891
[TBL] [Abstract][Full Text] [Related]
36. Development and validation of a rapid and sensitive UPLC-MS/MS method for determination of uracil and dihydrouracil in human plasma.
Jacobs BA; Rosing H; de Vries N; Meulendijks D; Henricks LM; Schellens JH; Beijnen JH
J Pharm Biomed Anal; 2016 Jul; 126():75-82. PubMed ID: 27179185
[TBL] [Abstract][Full Text] [Related]
37. Implications of dihydropyrimidine dehydrogenase on 5-fluorouracil pharmacogenetics and pharmacogenomics.
Mattison LK; Soong R; Diasio RB
Pharmacogenomics; 2002 Jul; 3(4):485-92. PubMed ID: 12164772
[TBL] [Abstract][Full Text] [Related]
38. Circadian rhythm of rat liver dihydropyrimidine dehydrogenase. Possible relevance to fluoropyrimidine chemotherapy.
Harris BE; Song RL; He YJ; Soong SJ; Diasio RB
Biochem Pharmacol; 1988 Dec; 37(24):4759-62. PubMed ID: 3202908
[TBL] [Abstract][Full Text] [Related]
39. Dihydropyrimidine dehydrogenase (DPD) and clinical pharmacology of 5-fluorouracil (review).
Milano G; Etienne MC
Anticancer Res; 1994; 14(6A):2295-7. PubMed ID: 7825962
[TBL] [Abstract][Full Text] [Related]
40. DPD functional tests in plasma, fresh saliva and dried saliva samples as predictors of 5-fluorouracil exposure and occurrence of drug-related severe toxicity.
Neto OV; Raymundo S; Franzoi MA; do Carmo Artmann A; Tegner M; Müller VV; Hahn RZ; Alves GV; Schwartsmann G; Linden R; Antunes MV
Clin Biochem; 2018 Jun; 56():18-25. PubMed ID: 29625079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
